LITTLE FALLS, N.J., Nov. 1, 2013 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that for the second consecutive year, it was named to the Forbes list of the "100 Best Small Companies in America." The Company was ranked number 67 on the Forbes 2013 list.
Cantel's President and CEO, Andrew Krakauer stated, "We are pleased to have been recognized for the success the Company has achieved both this year and over the past five years. I share this honor with our 1,300 hardworking and loyal employees. As a leader in the growing infection prevention and control market, the Company has performed well despite the difficult economic environment. We are optimistic that Cantel is positioned for sustained growth in the future. Our entire organization has a great sense of pride in providing the products, services and the guidance to mitigate infection risks, improve safety, and ultimately help save lives."
The Forbes rankings are based on one and five-year earnings growth, sales growth and return on equity. To qualify, companies must have sales between $5 million and $1 billion, and meet certain share price and other criteria. Forbes also considers a company's stock performance with its industry peers during the last year.
About Cantel Medical Corp. Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE Cantel Medical Corp.